Head and Neck TumorsHead and Neck TumorsОпухоли головы и шеи2222-14682411-4634Publishing House ABV Press23610.17650/2222-1468-2017-7-1-50-60DIAGNOSIS AND TREATMENT OF HEAD AND NECK TUMORSДИАГНОСТИКА И ЛЕЧЕНИЕ ОПУХОЛЕЙ ГОЛОВЫ И ШЕИNutritional support as an obligatory component of accompanying therapy for head and neck tumors during radiotherapy and chemoradiotherapyНутритивная поддержка как обязательный компонент терапии сопровождения при лучевом и химиолучевом лечении больных с опухолями головы и шеиBoykoA. V.БойкоА. В.
Russian Federation

Department of Beam Therapy Modification

3 2nd Botkinskiy proezd, Moscow 125284, Russia

Отделение лучевой терапии с модификацией

Россия, 125284 Москва, 2-й Боткинский пр-д, 3

GevorkovA. R.ГеворковА. Р.
Russian Federation

Department of Beam Therapy Modification

3 2nd Botkinskiy proezd, Moscow 125284, Russia

Отделение лучевой терапии с модификацией

Россия, 125284 Москва, 2-й Боткинский пр-д, 3

dr.gevorkov@gmail.comVolkovaE. E.ВолковаЕ. Э.
Russian Federation

26th km of the Baltiya highway, Krasnogorsk Region, Moscow Region 143421, Russia

Россия, 143421 МО, Красногорский район, 26-й км автодороги «Балтия», БЦ «Рига Лэнд», блок В

ShashkovS. V.ШашковС. В.
Russian Federation

Department of Beam Therapy Modification

3 2nd Botkinskiy proezd, Moscow 125284, Russia

Отделение лучевой терапии с модификацией

Россия, 125284 Москва, 2-й Боткинский пр-д, 3

P.A. Hertzen Moscow Oncology Research Institute – branch of the National Medical Research Radiological Center at the Ministry of Health of RussiaМосковский научно-исследовательский онкологический институт им. П.А. Герцена – филиала ФГБУ «Национальный медицинский исследовательский радиологический центр» Минздрава РоссииNutricia Advance, block V, Business Center “Riga-Land”ООО «Нутриция Эдванс»020420177150600204201702042017Copyright ©; 2017, Boyko A.V., Gevorkov A.R., Volkova E.E., Shashkov S.V.Copyright ©; 2017, Бойко А.В., Геворков А.Р., Волкова Е.Э., Шашков С.В.2017Boyko A.V., Gevorkov A.R., Volkova E.E., Shashkov S.V.Бойко А.В., Геворков А.Р., Волкова Е.Э., Шашков С.В.https://creativecommons.org/licenses/by/4.0https://ogsh.abvpress.ru/jour/article/view/236

The article considers supportive therapy in patients with head and neck tumors during radiotherapy and chemoradiotherapy. Special attention is given to nutritional support on every stage of patient care. The main methods of evaluation of nutritional status and risks are presented, as well as principles of clinical nutrition selection.

Публикация посвящена вопросам терапии сопровождения при лучевом и химиолучевом лечении больных с опухолями головы и шеи. Особое внимание уделено роли нутритивной поддержки на всех этапах ведения пациентов. Представлены основные методы оценки нутритивного статуса и рисков, а также принципы выбора вариантов лечебного питания.

head and neck tumorsnutritional deficiencychemoradiotherapysupportive therapyquality of lifeопухоли головы и шеинутритивная недостаточностьхимиолучевая терапиятерапия сопровождениякачество жизни больных1. Состояние онкологической помощи населению России в 2015 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2016. [State of oncological care in Russia in 2015. Editors: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI imeni P.A. Hertzena – filial FGBU “NMIRC” Minzdrava Rossii, 2016. (In Russ.)].Состояние онкологической помощи населению России в 2015 году. Под ред. А.Д. Каприна, В.В. Старинского, Г.В. Петровой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИРЦ» Минздрава России, 2016. [State of oncological care in Russia in 2015. Editors: A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: MNIOI imeni P.A. Hertzena – filial FGBU “NMIRC” Minzdrava Rossii, 2016. (In Russ.)].2. The Global Burden of Cancer 2015. Global Burden of Disease Cancer Collaboration. JAMA Oncol. Published online December 3, 2016. http://jamanetwork.com/journals/jamaoncology/article-abstract/2588797The Global Burden of Cancer 2015. Global Burden of Disease Cancer Collaboration. JAMA Oncol. Published online December 3, 2016. http://jamanetwork.com/journals/jamaoncology/article-abstract/25887973. Radiation Oncology: An Evidence-Based Approach. Ed. by J.J. Lu, L.W. Brady. New York: Springer, 2008.Radiation Oncology: An Evidence-Based Approach. Ed. by J.J. Lu, L.W. Brady. New York: Springer, 2008.4. Pignon J.P., le Maître A., Maillard E., Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Rad Oncol 2009:92;4–14. DOI: 10.1016/j.radonc.2009.04.014. PMID: 19446902.Pignon J.P., le Maître A., Maillard E., Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Rad Oncol 2009:92;4–14. DOI: 10.1016/j.radonc.2009.04.014. PMID: 19446902.5. Handbook of Evidence-Based Radiation Oncology. By eds.: E.K. Hansen Roach III Mack. Springer, 2010.Handbook of Evidence-Based Radiation Oncology. By eds.: E.K. Hansen Roach III Mack. Springer, 2010.6. Adelstein D.J., Li Y., Adams G.L. et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21(1):92–8. DOI: 10.1200/JCO.2003.01.008. PMID: 12506176.Adelstein D.J., Li Y., Adams G.L. et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21(1):92–8. DOI: 10.1200/JCO.2003.01.008. PMID: 12506176.7. Pignon J.P., Bourhis J., Domenge C., Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three metaanalyses of updated individual data. MACH-NC Collaborative Group. Meta- Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355(9208):949–55. PMID: 10768432.Pignon J.P., Bourhis J., Domenge C., Designé L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three metaanalyses of updated individual data. MACH-NC Collaborative Group. Meta- Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355(9208):949–55. PMID: 10768432.8. Bourhis J., Amand C., Pignon J.P. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy. J Clin Oncol, ASCO Annual Meeting Proceedings (Post-Meeting Edition) 2004;22:5505.Bourhis J., Amand C., Pignon J.P. Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy. J Clin Oncol, ASCO Annual Meeting Proceedings (Post-Meeting Edition) 2004;22:5505.9. Calais G., Alfonsi M., Bardet E. et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91(24):2081–6. PMID: 10601378.Calais G., Alfonsi M., Bardet E. et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst 1999;91(24):2081–6. PMID: 10601378.10. Brizel D.M., Albers M.E., Fisher S.R. et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338(25):1798–804.Brizel D.M., Albers M.E., Fisher S.R. et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338(25):1798–804.11. Posner M.R., Hershock D., Le Lann L. et al. TAX 324: A phase III trial at TPF vs. PF induction chemotherapy followed chemoradiotherapy in locally advanced SCCHN. Paper presented at American Society of Clinical Oncology (ASCO) annual meeting, Atlanta GA, 2006.Posner M.R., Hershock D., Le Lann L. et al. TAX 324: A phase III trial at TPF vs. PF induction chemotherapy followed chemoradiotherapy in locally advanced SCCHN. Paper presented at American Society of Clinical Oncology (ASCO) annual meeting, Atlanta GA, 2006.12. Scully С., Epstein J., Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head Neck 2004;26(1):77–84. DOI: 10.1002/hed.10326. PMID: 14724910.Scully С., Epstein J., Sonis S. Oral mucositis: a challenging complication of radiotherapy, chemotherapy and radiochemotherapy. Part 2: diagnosis and management of mucositis. Head Neck 2004;26(1):77–84. DOI: 10.1002/hed.10326. PMID: 14724910.13. Argiris A., Brockstein B.E., Haraf D.J. et al. Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res 2004;10:1956–62. DOI: 10.1158/1078-0432.CCR-03- 1077. PMID: 15041712.Argiris A., Brockstein B.E., Haraf D.J. et al. Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clin Cancer Res 2004;10:1956–62. DOI: 10.1158/1078-0432.CCR-03- 1077. PMID: 15041712.14. Epstein J.B., Thariat J., Bensadoun R.J. et al. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 2012;62(6):400–22. DOI: 10.3322/caac.21157. PMID: 22972543.Epstein J.B., Thariat J., Bensadoun R.J. et al. Oral complications of cancer and cancer therapy: from cancer treatment to survivorship. CA Cancer J Clin 2012;62(6):400–22. DOI: 10.3322/caac.21157. PMID: 22972543.15. Kang H.S., Roh J.L., Lee S. et al. Noncancer-related health events and mortality in head and neck cancer patients after definitive radiotherapy: a prospective study. Medicine (Baltimore) 2016;95(19):e3403. DOI: 10.1097/MD.0000000000003403.Kang H.S., Roh J.L., Lee S. et al. Noncancer-related health events and mortality in head and neck cancer patients after definitive radiotherapy: a prospective study. Medicine (Baltimore) 2016;95(19):e3403. DOI: 10.1097/MD.0000000000003403.16. Bensinger W., Schubert M., Ang K.K. et al. NCCN Task Force Report. prevention and management of mucositis in cancer care. J Natl Compr Canc Netw 2008;6(Suppl 1):1– 21;quiz S22–4. PMID: 18289497.Bensinger W., Schubert M., Ang K.K. et al. NCCN Task Force Report. prevention and management of mucositis in cancer care. J Natl Compr Canc Netw 2008;6(Suppl 1):1– 21;quiz S22–4. PMID: 18289497.17. Rosenthal D.I., Trotti A. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 2009;19:29–34. DOI: 10.1016/j.semradonc.2008.09.006. PMID: 19028343.Rosenthal D.I., Trotti A. Strategies for managing radiation-induced mucositis in head and neck cancer. Semin Radiat Oncol 2009;19:29–34. DOI: 10.1016/j.semradonc.2008.09.006. PMID: 19028343.18. Trotti A., Bellm L.A., Epstein J.B. et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 2003;66:253–62. DOI: 10.1016/S0167-8140(02)00404-8. PMID: 12742264.Trotti A., Bellm L.A., Epstein J.B. et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review. Radiother Oncol 2003;66:253–62. DOI: 10.1016/S0167-8140(02)00404-8. PMID: 12742264.19. Campos M.I., Campos C.N., Aarestrup F.M., Aarestrup B.J. Oral mucositis in cancer treatment: natural history, prevention and treatment. Mol Clin Oncol 2014;2,337–40. DOI: 10.3892/mco.2014.253 PMID: 24772297.Campos M.I., Campos C.N., Aarestrup F.M., Aarestrup B.J. Oral mucositis in cancer treatment: natural history, prevention and treatment. Mol Clin Oncol 2014;2,337–40. DOI: 10.3892/mco.2014.253 PMID: 24772297.20. Zhu G., Lin J., Kim S. et al. Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma. BMC Cancer 2016;16:42. DOI: 10.1186/s12885-016-2073-z. PMID: PMC4730602.Zhu G., Lin J., Kim S. et al. Asian expert recommendation on management of skin and mucosal effects of radiation, with or without the addition of cetuximab or chemotherapy, in treatment of head and neck squamous cell carcinoma. BMC Cancer 2016;16:42. DOI: 10.1186/s12885-016-2073-z. PMID: PMC4730602.21. NCCN Guidelines. Version 2.2016. Available at: www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.NCCN Guidelines. Version 2.2016. Available at: www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf.22. Vera-Llonch M., Oster G., Hagiwara M., Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 2006;106:329–36. DOI: 10.1002/cncr.21622. PMID: 16342066.Vera-Llonch M., Oster G., Hagiwara M., Sonis S. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma. Cancer 2006;106:329–36. DOI: 10.1002/cncr.21622. PMID: 16342066.23. Mortensen H.R., Overgaard J., Jensen K. et al. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer. Acta Oncol 2013;52:1535–42. DOI: 10.3109/0284186X.2013.824609. PMID: 24047339.Mortensen H.R., Overgaard J., Jensen K. et al. Factors associated with acute and late dysphagia in the DAHANCA 6 & 7 randomized trial with accelerated radiotherapy for head and neck cancer. Acta Oncol 2013;52:1535–42. DOI: 10.3109/0284186X.2013.824609. PMID: 24047339.24. Barrera R. Nutritional support in cancer patients. J Parenter Enteral Nutr 2002;26(5):63– 71. DOI: 10.1177/014860710202600516. PMID: 12216725.Barrera R. Nutritional support in cancer patients. J Parenter Enteral Nutr 2002;26(5):63– 71. DOI: 10.1177/014860710202600516. PMID: 12216725.25. Bloch A. Nutrition support in cancer. Semin Oncol Nurs 2000;16(2):122–7. DOI: 10.1053/on.2000.5555.Bloch A. Nutrition support in cancer. Semin Oncol Nurs 2000;16(2):122–7. DOI: 10.1053/on.2000.5555.26. Bozzetti F., Gavazzi C., Miceli R. Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. J Parenter Enteral Nutr 2000;24(1):7–14. DOI: 10.1177/014860710002400107. PMID: 10638466.Bozzetti F., Gavazzi C., Miceli R. Perioperative total parenteral nutrition in malnourished, gastrointestinal cancer patients: a randomized, clinical trial. J Parenter Enteral Nutr 2000;24(1):7–14. DOI: 10.1177/014860710002400107. PMID: 10638466.27. Bozzetti F. Nutrition and gastrointestinal cancer. Curr Opin Clin Nutr Metab Care 2001;4(6):541–6. DOI: 10.1097/00075197-200111000-00014. PMID: 11706291.Bozzetti F. Nutrition and gastrointestinal cancer. Curr Opin Clin Nutr Metab Care 2001;4(6):541–6. DOI: 10.1097/00075197-200111000-00014. PMID: 11706291.28. Langius J.A., Doornaert P., Spreeuwenberg M.D. et al. Radiotherapy on the neck nodes predicts severe weight loss in patients with early stage laryngeal cancer. Radiother Oncol 2010;97(1):80–5. DOI: 10.1016/j.radonc.2010.02.017. PMID: 20223540.Langius J.A., Doornaert P., Spreeuwenberg M.D. et al. Radiotherapy on the neck nodes predicts severe weight loss in patients with early stage laryngeal cancer. Radiother Oncol 2010;97(1):80–5. DOI: 10.1016/j.radonc.2010.02.017. PMID: 20223540.29. Matthews T.W., Lampe H.B., Dragosz K. Nutritional status in head and neck cancer patients. J Otolaryngol 1995;24(2):87–91. PMID: 7602677.Matthews T.W., Lampe H.B., Dragosz K. Nutritional status in head and neck cancer patients. J Otolaryngol 1995;24(2):87–91. PMID: 7602677.30. Unsal D., Mentes B., Akmansu M. et al. Evaluation of nutritional status in cancer patients receiving radiotherapy: a prospective study. Am J Clin Oncol 2006;29(2):183–8. DOI: 10.1097/01.coc.0000198745.94757.ee. PMID: 16601440.Unsal D., Mentes B., Akmansu M. et al. Evaluation of nutritional status in cancer patients receiving radiotherapy: a prospective study. Am J Clin Oncol 2006;29(2):183–8. DOI: 10.1097/01.coc.0000198745.94757.ee. PMID: 16601440.31. Meyer F., Fortin A., Wang C.S. et al. Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys 2012;82(4):1454–62. DOI: 10.1016/j.ijrobp.2011.04.022. PMID: 21640495.Meyer F., Fortin A., Wang C.S. et al. Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys 2012;82(4):1454–62. DOI: 10.1016/j.ijrobp.2011.04.022. PMID: 21640495.32. Capuano G., Grosso A., Gentile P.C. et al. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck 2008;30(4):503–8. DOI: 10.1002/hed.20737. PMID: 18098310.Capuano G., Grosso A., Gentile P.C. et al. Influence of weight loss on outcomes in patients with head and neck cancer undergoing concomitant chemoradiotherapy. Head Neck 2008;30(4):503–8. DOI: 10.1002/hed.20737. PMID: 18098310.33. Langius J.A., van Dijk A.M., Doornaert P. et al. More than 10 % weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life. Nutr Cancer 2013;65(1):76–83. DOI: 10.1080/01635581.2013.741749. PMID: 23368916.Langius J.A., van Dijk A.M., Doornaert P. et al. More than 10 % weight loss in head and neck cancer patients during radiotherapy is independently associated with deterioration in quality of life. Nutr Cancer 2013;65(1):76–83. DOI: 10.1080/01635581.2013.741749. PMID: 23368916.34. Mourad W.F., Hu K.S., Puckett L. et al. Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy. Am J Clin Oncol 2014;37:57–62. DOI: 10.1097/COC.0b013e31826b9920. PMID: 23357967.Mourad W.F., Hu K.S., Puckett L. et al. Five-year outcomes of squamous cell carcinoma of the tonsil treated with radiotherapy. Am J Clin Oncol 2014;37:57–62. DOI: 10.1097/COC.0b013e31826b9920. PMID: 23357967.35. Prevost V., Joubert C., Heutte N., Babin E. Assessment of nutritional status and quality of life in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131:112–20. DOI: 10.1016/j.anorl.2013.06.007. PMID: 24657191.Prevost V., Joubert C., Heutte N., Babin E. Assessment of nutritional status and quality of life in patients treated for head and neck cancer. Eur Ann Otorhinolaryngol Head Neck Dis 2014;131:112–20. DOI: 10.1016/j.anorl.2013.06.007. PMID: 24657191.36. Горбунова В.А., Бредер В.В. Качество жизни онкологических больных. Материалы IV ежегодной Российской онкологической конференции, 21–23 ноября 2000 г., Москва. С. 125. Доступно по: http://www.rosoncoweb.ru/library/congress/ru/04/43.php. [Gorbunova V.A., Breder V.V. Quality of life of oncological patients. Proceedings of the IV Annual Russian Oncological Conference, November 21–23, 2000, Moscow. P. 125. Available at: http://www.rosoncoweb.ru/library/congress/ru/04/43.php. (In Russ.)].Горбунова В.А., Бредер В.В. Качество жизни онкологических больных. Материалы IV ежегодной Российской онкологической конференции, 21–23 ноября 2000 г., Москва. С. 125. Доступно по: http://www.rosoncoweb.ru/library/congress/ru/04/43.php. [Gorbunova V.A., Breder V.V. Quality of life of oncological patients. Proceedings of the IV Annual Russian Oncological Conference, November 21–23, 2000, Moscow. P. 125. Available at: http://www.rosoncoweb.ru/library/congress/ru/04/43.php. (In Russ.)].37. Kumari A.C., Shanmughakumar S., Balasubramaniam P. Assessment of quality of life in head and neck cancer patients with enteral tube feeding. J Cancer Res Therapeutic 2012;8:176.Kumari A.C., Shanmughakumar S., Balasubramaniam P. Assessment of quality of life in head and neck cancer patients with enteral tube feeding. J Cancer Res Therapeutic 2012;8:176.38. Husaini H., Lazarus C., Hu K. et al. EORTC QOL rating, performance status, and oral outcomes in head-and-neck cancer patients treated with chemoradiation therapy. Int J Radiat Oncol Biol Phys 2013;87:441–2.Husaini H., Lazarus C., Hu K. et al. EORTC QOL rating, performance status, and oral outcomes in head-and-neck cancer patients treated with chemoradiation therapy. Int J Radiat Oncol Biol Phys 2013;87:441–2.39. Практические рекомендации RUSSCO по нутритивной поддержке онкологических больных, 2016 г. Доступно по: www.rosoncoweb.ru/standarts/RUSSCO/2016/40.pdf. [RUSSCO practical guidelines on nutritional support in oncological patients, 2016. Available at: www.rosoncoweb.ru/standarts/RUSSCO/2016/40.pdf. (In Russ.)].Практические рекомендации RUSSCO по нутритивной поддержке онкологических больных, 2016 г. Доступно по: www.rosoncoweb.ru/standarts/RUSSCO/2016/40.pdf. [RUSSCO practical guidelines on nutritional support in oncological patients, 2016. Available at: www.rosoncoweb.ru/standarts/RUSSCO/2016/40.pdf. (In Russ.)].40. Обухова О.А., Курмуков И.А., Кашия Ш.Р. Питательная поддержка в онкологии. Онкогинекология 2014;1:34–45. www.osors.com/oncogynecology/JurText/j2014_1/01_14_C34.pdf. [Obukhova O.A., Kurmukov I.A., Kashiya Sh.R. Nutritional support in oncology. Onkoginekologiya = Oncogynecology 2014;1:34–45. Available at: www.osors.com/oncogynecology/JurText/j2014_1/01_14_C34.pdf (In Russ.)].Обухова О.А., Курмуков И.А., Кашия Ш.Р. Питательная поддержка в онкологии. Онкогинекология 2014;1:34–45. www.osors.com/oncogynecology/JurText/j2014_1/01_14_C34.pdf. [Obukhova O.A., Kurmukov I.A., Kashiya Sh.R. Nutritional support in oncology. Onkoginekologiya = Oncogynecology 2014;1:34–45. Available at: www.osors.com/oncogynecology/JurText/j2014_1/01_14_C34.pdf (In Russ.)].41. ESPEN Guidelines for Nutrition Screening 2002 Clin Nutr 2003;22(4):415–21.ESPEN Guidelines for Nutrition Screening 2002 Clin Nutr 2003;22(4):415–21.42. Duguet A., Bachmann P., Lallemand Y. Summary report of the standards, options and recommendations for malnutrition and nutritional assessment in patients with cancer. Br J Cancer 2003;89(1):92–7. DOI: 10.1038/sj.bjc.6601089. PMID: PMC2753013.Duguet A., Bachmann P., Lallemand Y. Summary report of the standards, options and recommendations for malnutrition and nutritional assessment in patients with cancer. Br J Cancer 2003;89(1):92–7. DOI: 10.1038/sj.bjc.6601089. PMID: PMC2753013.43. Heys S.D., Schofield A. C., Wahle K.W., Garcia-Caballero M. Nutrition and the surgical patient: triumphs and challenges. Surgeon 2005;3(3):139–44. PMID: 16075997.Heys S.D., Schofield A. C., Wahle K.W., Garcia-Caballero M. Nutrition and the surgical patient: triumphs and challenges. Surgeon 2005;3(3):139–44. PMID: 16075997.44. Снеговой А.В., Сельчук В.Ю., Салтанов А.И. Нутрикомп АДН Браун Файбер у больных раком желудка с послеоперационными осложнениями. Вестник интенсивной терапии 2003;2:86–7. [Snegovoy A.V., Selchuk V.Yu., Saltanov A.I. Nutricomp ADN Brown Fibre in patients with stomach cancer and postoperative complications. Vestnik intensivnoy terapii = Intensive Care Herald 2003;2:86–7. (In Russ.)].Снеговой А.В., Сельчук В.Ю., Салтанов А.И. Нутрикомп АДН Браун Файбер у больных раком желудка с послеоперационными осложнениями. Вестник интенсивной терапии 2003;2:86–7. [Snegovoy A.V., Selchuk V.Yu., Saltanov A.I. Nutricomp ADN Brown Fibre in patients with stomach cancer and postoperative complications. Vestnik intensivnoy terapii = Intensive Care Herald 2003;2:86–7. (In Russ.)].45. Снеговой А.В., Лейдерман И.Н., Салтанов А.И., Стрельчук В.Ю. Основные принципы и технологии клинического питания в онкологии: Методическое руководство для врачей. М., 2006. [Snegovoy A.V., Leyderman I.N., Saltanov A.I., Strelchuk V.Yu. Main principles and technologies of clinical nutrition in oncology: Guidelines for doctors. Moscow: 2006. (In Russ.)].Снеговой А.В., Лейдерман И.Н., Салтанов А.И., Стрельчук В.Ю. Основные принципы и технологии клинического питания в онкологии: Методическое руководство для врачей. М., 2006. [Snegovoy A.V., Leyderman I.N., Saltanov A.I., Strelchuk V.Yu. Main principles and technologies of clinical nutrition in oncology: Guidelines for doctors. Moscow: 2006. (In Russ.)].46. Sánchez Alvarez C., Nuñez Ruiz R., Morán García V. Nutritional support in the patient with GI malignancy. Nutr Hosp 2005;20(2):38–40.Sánchez Alvarez C., Nuñez Ruiz R., Morán García V. Nutritional support in the patient with GI malignancy. Nutr Hosp 2005;20(2):38–40.47. Луфт В.М., Луфт А.В. Нутриционная поддержка онкологических больных: возможности и противоречия. Вестник интенсивной терапии 2008;2:43–50. [Luft V.M., Luft A.V. Nutritional support of oncological patients: Possibilities and challenges. Vestnik intensivnoy terapii = Intensive Care Herald 2008;2:43–50. (In Russ.)].Луфт В.М., Луфт А.В. Нутриционная поддержка онкологических больных: возможности и противоречия. Вестник интенсивной терапии 2008;2:43–50. [Luft V.M., Luft A.V. Nutritional support of oncological patients: Possibilities and challenges. Vestnik intensivnoy terapii = Intensive Care Herald 2008;2:43–50. (In Russ.)].48. Лучевая терапия злокачественных опухолей. Рук-во для врачей. Под ред. Е.С. Киселевой. М.: Медицина, 1996. Beam therapy of malignant tumors. Guidelines for doctors. Ed. E.S. Kiselyova. Moscow: Meditsina, 1996. (In Russ.)].Лучевая терапия злокачественных опухолей. Рук-во для врачей. Под ред. Е.С. Киселевой. М.: Медицина, 1996. Beam therapy of malignant tumors. Guidelines for doctors. Ed. E.S. Kiselyova. Moscow: Meditsina, 1996. (In Russ.)].49. Ярмоненко С.П., Коноплянников А.Г., Вайнсон А.А. Клиническая радиобиология. М.: Медицина, 1992. [Yarmonenko S.P., Konoplyannikov A.G., Vaynson A.A. Clinical radiobiology. Moscow: Meditsina, 1992. (In Russ.)].Ярмоненко С.П., Коноплянников А.Г., Вайнсон А.А. Клиническая радиобиология. М.: Медицина, 1992. [Yarmonenko S.P., Konoplyannikov A.G., Vaynson A.A. Clinical radiobiology. Moscow: Meditsina, 1992. (In Russ.)].50. Roopashri G., Jayanthi K. Radiotherapy and chemotherapy induced oral mucositis – prevention and current therapeutic modalities. IJDA 2010;2:174–9.Roopashri G., Jayanthi K. Radiotherapy and chemotherapy induced oral mucositis – prevention and current therapeutic modalities. IJDA 2010;2:174–9.51. Гладилина И.А., Шабанов М.А. Лучевое и химиолучевое лечение распространенного рака ротоглотки. Тверь: Губернская медицина, 2001. [Gladilina I.A., Shabanov M.A. Beam therapy and chemoradiotherapy of advanced oropharyngeal cancer. Tver: Gubernskaya meditsina, 2001. (In Russ.)].Гладилина И.А., Шабанов М.А. Лучевое и химиолучевое лечение распространенного рака ротоглотки. Тверь: Губернская медицина, 2001. [Gladilina I.A., Shabanov M.A. Beam therapy and chemoradiotherapy of advanced oropharyngeal cancer. Tver: Gubernskaya meditsina, 2001. (In Russ.)].52. Алиева С.Б., Ткачев С.И., Любаев В.Л. и др. Химиолучевая терапия местнораспространенного рака головы и шеи III–IV стадии. Вестник РОНЦ им. Н.Н. Блохина РАМН 2007;18(2): 39–42. [Alieva S.B., Tkachev S.I., Lubaev V.L. et al. Chemoradiotherapy of stage III–IV locally advanced head and neck cancer. Vestnik RONC im. Blokhina = Journal of N.N. Blokhin Russian Cancer Research Center RAMS 2007;18(2):39–42. (In Russ.)].Алиева С.Б., Ткачев С.И., Любаев В.Л. и др. Химиолучевая терапия местнораспространенного рака головы и шеи III–IV стадии. Вестник РОНЦ им. Н.Н. Блохина РАМН 2007;18(2): 39–42. [Alieva S.B., Tkachev S.I., Lubaev V.L. et al. Chemoradiotherapy of stage III–IV locally advanced head and neck cancer. Vestnik RONC im. Blokhina = Journal of N.N. Blokhin Russian Cancer Research Center RAMS 2007;18(2):39–42. (In Russ.)].53. Сопроводительная терапия в онкологии. Практическое руководство. Под ред. С.Ю. Мооркрафта, Д.Л.Ю. Ли, Д. Каннингэма; пер. с англ.; Под ред. А.Д. Каприна. М.: Гэотар, 2016. [Clinical problems in oncology: A practical guide to management. Eds. S.Y. Moorkraft, D.L.Y. Lee, D.D. Cunningham; Translation from English. Ed. A.D. Kaprin. Moscow: Geotar, 2016. (In Russ.)].Сопроводительная терапия в онкологии. Практическое руководство. Под ред. С.Ю. Мооркрафта, Д.Л.Ю. Ли, Д. Каннингэма; пер. с англ.; Под ред. А.Д. Каприна. М.: Гэотар, 2016. [Clinical problems in oncology: A practical guide to management. Eds. S.Y. Moorkraft, D.L.Y. Lee, D.D. Cunningham; Translation from English. Ed. A.D. Kaprin. Moscow: Geotar, 2016. (In Russ.)].54. Brady O., Donnelly M., Horgan A., Maher M. Post-radiotherapy side effects for head and neck cancer – the patient’s perspective. Proceedings of the Nutrition Society. Harrogate; p. E283.Brady O., Donnelly M., Horgan A., Maher M. Post-radiotherapy side effects for head and neck cancer – the patient’s perspective. Proceedings of the Nutrition Society. Harrogate; p. E283.55. Galloway T., Amdur R. Management and prevention of complications during initial treatment of head and neck cancer. In: Posner M., Brockstein B., Brizel D., Deschler D. (eds). UpToDate, Waltham, MA, 2014.Galloway T., Amdur R. Management and prevention of complications during initial treatment of head and neck cancer. In: Posner M., Brockstein B., Brizel D., Deschler D. (eds). UpToDate, Waltham, MA, 2014.56. Langius J.A., Zandbergen M.C., Van Tulder M.W. et al. Effect of nutritional interventions on nutritional status of patients with head and neck cancer receiving (chemo)radiotherapy: A systematic review. Clin Nutr 2013;32:671–8. DOI: 10.1016/j.clnu.2013.06.012. PMID: 23845384.Langius J.A., Zandbergen M.C., Van Tulder M.W. et al. Effect of nutritional interventions on nutritional status of patients with head and neck cancer receiving (chemo)radiotherapy: A systematic review. Clin Nutr 2013;32:671–8. DOI: 10.1016/j.clnu.2013.06.012. PMID: 23845384.57. Payakachat N., Ounpraseuth S., Suen J.Y. Late complications and long-term quality of life for survivors (>5 years) with history of head and neck cancer. Head Neck 2013;35:819–25. DOI: 10.1002/hed.23035. PMID: 22807083.Payakachat N., Ounpraseuth S., Suen J.Y. Late complications and long-term quality of life for survivors (>5 years) with history of head and neck cancer. Head Neck 2013;35:819–25. DOI: 10.1002/hed.23035. PMID: 22807083.58. Paleri V., Roe J.W.G., Strojan P. et al. Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: An evidence-based review: Strategies to reduce dysphagia after chemoradiation. Head Neck 2014;36: 431–43. DOI: 10.1002/hed.23251. PMID: 23828486.Paleri V., Roe J.W.G., Strojan P. et al. Strategies to reduce long-term postchemoradiation dysphagia in patients with head and neck cancer: An evidence-based review: Strategies to reduce dysphagia after chemoradiation. Head Neck 2014;36: 431–43. DOI: 10.1002/hed.23251. PMID: 23828486.59. Wendt T.G., Grabenbauer G.G., Rodel C.M. et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 1998;16:1318– 24. DOI: 10.1200/JCO.1998.16.4.1318. PMID: 9552032.Wendt T.G., Grabenbauer G.G., Rodel C.M. et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 1998;16:1318– 24. DOI: 10.1200/JCO.1998.16.4.1318. PMID: 9552032.60. Практические рекомендации по лекарственному лечению злокачественных опухолей (RUSSCO). Под ред. В.М. Моисеенко. М.: Изд-е Российского общества клинической онкологии, 2015.Доступно по: http://www.rosoncoweb.ru/standarts/RUSSCO/2014/. [Practical guidelines on drug therapy of malignant tumors (RUSSCO). Ed. V.M. Moiseenko. Moscow: Izdanie Rossiyskogo Obshchestva klinicheskoy onkologii, 2015. (In Russ.)].Практические рекомендации по лекарственному лечению злокачественных опухолей (RUSSCO). Под ред. В.М. Моисеенко. М.: Изд-е Российского общества клинической онкологии, 2015.Доступно по: http://www.rosoncoweb.ru/standarts/RUSSCO/2014/. [Practical guidelines on drug therapy of malignant tumors (RUSSCO). Ed. V.M. Moiseenko. Moscow: Izdanie Rossiyskogo Obshchestva klinicheskoy onkologii, 2015. (In Russ.)].61. Bonner J.A., Harari P.M., Giralt J. et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab- induced rash and survival. Lancet Oncol 2010;11:21–8. DOI: 10.1016/S1470-2045(09)70311-0. PMID: 19897418.Bonner J.A., Harari P.M., Giralt J. et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab- induced rash and survival. Lancet Oncol 2010;11:21–8. DOI: 10.1016/S1470-2045(09)70311-0. PMID: 19897418.62. Curran D., Giralt J., Harari P.M. et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 2007;25:2191–7. DOI: 10.1200/JCO.2006.08.8005. PMID: 17538164.Curran D., Giralt J., Harari P.M. et al. Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab. J Clin Oncol 2007;25:2191–7. DOI: 10.1200/JCO.2006.08.8005. PMID: 17538164.63. Bozzetti F., Bozzetti V. Efficacy of enteral and parenteral nutrition in cancer patients. Nestle Nutr Workshop Ser Clin Perform Programme 2005;10:127–39. DOI: 10.1159/000083302. PMID: 15818026.Bozzetti F., Bozzetti V. Efficacy of enteral and parenteral nutrition in cancer patients. Nestle Nutr Workshop Ser Clin Perform Programme 2005;10:127–39. DOI: 10.1159/000083302. PMID: 15818026.64. Снеговой А.В., Салтанов А.И., Манзюк Л.В. и др. Оценка эффективности нутритивной поддержки энтеральной смесью «Фортикер» у пациентов с онкологическими заболеваниями в период лучевой и химиотерапии. Вестник интенсивной терапии 2009;(4):77–83. [Snegovoy A.V., Saltanov A.I., Manzuk L.V. et al. Evaluation of effectiveness of Forticare enteral mixture in patients with oncological diseases during beam therapy and chemoradiotherapy. Vestnik intensivnoy terapii = Intensive Care Herald 2009;(4):77–83. (In Russ.)].Снеговой А.В., Салтанов А.И., Манзюк Л.В. и др. Оценка эффективности нутритивной поддержки энтеральной смесью «Фортикер» у пациентов с онкологическими заболеваниями в период лучевой и химиотерапии. Вестник интенсивной терапии 2009;(4):77–83. [Snegovoy A.V., Saltanov A.I., Manzuk L.V. et al. Evaluation of effectiveness of Forticare enteral mixture in patients with oncological diseases during beam therapy and chemoradiotherapy. Vestnik intensivnoy terapii = Intensive Care Herald 2009;(4):77–83. (In Russ.)].65. Решетов И.В., Егоров Г.Н. Предоперационная нутритивная терапия пациентов с опухолями головы и шеи. Голова и шея 2013;2:27–34. [Reshetov I.V., Egorov G.N. Preoperative nutritional therapy in patients with head and neck tumors. Golova i sheya = Head and Neck 2013;(2):27–34. (In Russ.)].Решетов И.В., Егоров Г.Н. Предоперационная нутритивная терапия пациентов с опухолями головы и шеи. Голова и шея 2013;2:27–34. [Reshetov I.V., Egorov G.N. Preoperative nutritional therapy in patients with head and neck tumors. Golova i sheya = Head and Neck 2013;(2):27–34. (In Russ.)].66. Elia M., Van Bokhorst-de van der Schueren M.A., Garvey J. et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 2006;28(1):5–23. PMID: 16327975.Elia M., Van Bokhorst-de van der Schueren M.A., Garvey J. et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 2006;28(1):5–23. PMID: 16327975.67. Pauloski B.R. Rehabilitation of dysphagia following head and neck cancer. Phys Med Rehabil Clin N Am 2008;9:889–928. DOI: 10.1016/j.pmr.2008.05.010. PMID: 18940647.Pauloski B.R. Rehabilitation of dysphagia following head and neck cancer. Phys Med Rehabil Clin N Am 2008;9:889–928. DOI: 10.1016/j.pmr.2008.05.010. PMID: 18940647.